Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China · Delayed Price · Currency is CNY 46.52
+6.42 (16.01%)
Nov 2, 2026, 3:04 PM CST
Betta Pharmaceuticals Market Cap
Betta Pharmaceuticals has a market cap or net worth of 19.69 billion as of November 2, 2026. It is the 5,591st most valuable company in the world and the 898th biggest in China. Its market cap has decreased by 17.72% in one year.
Market Cap
19.69B
Enterprise Value
21.47B
Revenue
3.80B
Global Rank
Country Rank
#898 China
PE Ratio
73.57
ChartMarket Cap Chart
Since November 7, 2016, Betta Pharmaceuticals's market cap has increased from 10.15B to 19.69B, an increase of 94.11%. That is a compound annual growth rate of 6.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 19.69B | 0.25% |
| Dec 31, 2025 | 19.64B | -12.96% |
| Dec 31, 2024 | 22.57B | 4.62% |
| Dec 29, 2023 | 21.57B | 5.11% |
| Dec 30, 2022 | 20.53B | -38.09% |
| Dec 31, 2021 | 33.15B | -25.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Haoyuan Chemexpress | 19.64B |
| Hybio Pharmaceutical | 19.31B |
| Guangdong Zhongsheng Pharmaceutical | 18.72B |
| Joincare Pharmaceutical Group Industry | 18.39B |
| Kangmei Pharmaceutical | 17.70B |
| Walvax Biotechnology | 17.42B |
| Chengdu Kanghong Pharmaceutical Group | 17.32B |
| China Resources Double-Crane Pharmaceutical | 15.89B |